| (USD) | Mar 2026 | Y/Y change |
|---|---|---|
| Revenue | 12.42K | 96.21% |
| Operating expense | — | — |
| Net income | -5.02M | -17.12% |
| Net profit margin | — | — |
| Earnings per share | — | — |
| EBITDA | — | — |
| Effective tax rate | — | — |
Over the past year, VRAX returned -83.3% with dividends reinvested.
| Period | Total return |
|---|---|
| YTD | -63.1% |
| 1 year | -83.3% |
| All-time high | $1,350.00 (Jul 2022) |
Returns are total returns and include reinvested dividends. The all-time high is the highest monthly closing price on record.
See what $1,000 in VRAX would be worth today ›No. Virax Biolabs Group Limited has not paid a dividend in the past 12 months.
Virax Biolabs Group Limited stock trades on NASDAQ under the ticker symbol VRAX.
Virax Biolabs Group Limited is part of the Healthcare sector.
Virax Biolabs Group Limited has a market cap of 2.54M USD, based on the latest quote.
